aTyr Pharma, Inc. - stock earnings
LIFE Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 AfterMarket | - / -0.2407000000 | - | - / 20400 | - |
LIFE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -14.8 million USD | ? USD |
| 2023Q3 | -11.3 million USD | 353000 USD |
| 2023Q2 | -12.3 million USD | ? USD |
| 2023Q1 | -11.1 million USD | ? USD |
| 2022Q4 | -7.1 million USD | 10.4 million USD |
| 2022Q3 | -13.0 million USD | ? USD |
| 2022Q2 | -12.3 million USD | ? USD |
| 2022Q1 | -11.9 million USD | ? USD |
| 2021Q4 | -8.6 million USD | 10 USD |
| 2021Q3 | -7.7 million USD | ? USD |
| 2021Q2 | -10.4 million USD | 2790 USD |
| 2021Q1 | -7.2 million USD | 2686 USD |
| 2020Q4 | -4.9 million USD | 2.1 million USD |
| 2020Q3 | -6.6 million USD | 148000 USD |
| 2020Q2 | -6.4 million USD | 189000 USD |
| 2020Q1 | 1.8 million USD | 8.1 million USD |
| 2019Q4 | -6.0 million USD | 144000 USD |
| 2019Q3 | -5.6 million USD | 184000 USD |
| 2019Q2 | -5.8 million USD | 94000 USD |
| 2019Q1 | -6.1 million USD | ? USD |
| 2018Q4 | -6.3 million USD | ? USD |
| 2018Q3 | -7.1 million USD | ? USD |
| 2018Q2 | -10.4 million USD | ? USD |
| 2018Q1 | -10.7 million USD | ? USD |
| 2017Q4 | -11.5 million USD | ? USD |
| 2017Q3 | -11.2 million USD | ? USD |
| 2017Q2 | -12.1 million USD | ? USD |
| 2017Q1 | -13.4 million USD | ? USD |
| 2016Q4 | -12.6 million USD | ? USD |
| 2016Q3 | -13.8 million USD | ? USD |
| 2016Q2 | -15.4 million USD | ? USD |
| 2016Q1 | -16.1 million USD | ? USD |
| 2015Q4 | -16.5 million USD | ? USD |
| 2015Q3 | -11.3 million USD | ? USD |
| 2015Q2 | -11.1 million USD | ? USD |
| 2015Q1 | -9.1 million USD | ? USD |
| 2014Q4 | -6.0 million USD | ? USD |
| 2014Q3 | -6.6 million USD | ? USD |
| 2014Q2 | -5.6 million USD | ? USD |
| 2014Q1 | -6.1 million USD | ? USD |
| 2013Q4 | 8.4 million USD | 10.7 million USD |
| 2013Q3 | 118.2 million USD | 935.1 million USD |
| 2013Q2 | 126.6 million USD | 945.8 million USD |
| 2013Q1 | 121.2 million USD | 962.5 million USD |
| 2012Q4 | 110.0 million USD | 998.9 million USD |
| 2012Q3 | 65.9 million USD | 911.2 million USD |
| 2012Q2 | 122.4 million USD | 949.3 million USD |
| 2012Q1 | 132.6 million USD | 939.1 million USD |
| 2011Q4 | 93.1 million USD | 1.0 billion USD |
| 2011Q3 | 96.3 million USD | 928.2 million USD |
| 2011Q2 | 95.5 million USD | 941.1 million USD |
| 2011Q1 | 93.7 million USD | 895.9 million USD |
| 2010Q4 | 70.7 million USD | 932.3 million USD |
| 2010Q3 | 105.5 million USD | 867.1 million USD |
| 2010Q2 | 110.6 million USD | 903.7 million USD |
| 2010Q1 | 91.5 million USD | 884.9 million USD |
LIFE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.4 million USD | 353000 USD |
| 2022 | -44.3 million USD | 10.4 million USD |
| 2021 | -32.5 million USD | 10751 USD |
| 2020 | -15.0 million USD | 10.5 million USD |
| 2019 | -22.2 million USD | 422000 USD |
| 2018 | -34.5 million USD | ? USD |
| 2017 | -48.2 million USD | ? USD |
| 2016 | -57.9 million USD | ? USD |
| 2015 | -48.0 million USD | ? USD |
| 2014 | -24.4 million USD | ? USD |
| 2013 | -20.0 million USD | ? USD |
| 2012 | 430.9 million USD | 3.8 billion USD |
| 2011 | 378.5 million USD | 3.8 billion USD |
| 2010 | 378.3 million USD | 3.6 billion USD |
LIFE
Price: $1.69
52 week price:
Earnings Per Share: -0.94 USD
P/E Ratio: -1.77
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 171300
Ebitda: -10.7 millionMarket Capitalization: 113.8 million